Skip to content

ANRO - Alto Neuroscience, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Alto Neuroscience, Inc.

ANRO · NYSE

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ANROAlto Neuroscience, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $35.34
52-wk low: $3.41
Prev close: $19.92
Mkt cap: $1.37B
Beta: 1.09
P/B: 6.1x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$123.4M

MI
Millennium
Israel Englander · Q2 2026 13F
$14.7M
position
P7
Point72
Steven Cohen · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.4B

Valuation

P/B6.11

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ANRO
Exchange: NYSE
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.37B
Beta: 1.09

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-49.2%

$13.3M

position

SC

Schonfeld

Steven Schonfeld · Q2 2026 13F

$6.8M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ANRO

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

EPS expected

-$0.71

-$0.89 to -$0.60

Revenue expected

$0.00

9 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

+0.09

Change in 30 days

-49.2%

ROA-26.8%

Growth

Beta1.09